Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine.
D000970:Antineoplastic Agents / Q000378:metabolism*; D001201:Ascites; D001377:Azaserine; D003980:Diazooxonorleucine; D007930:Leucine / Q000031:analogs & derivatives; D009369:Neoplasms / Q000378:metabolism*; D012694:Serine / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D003980:Diazooxonorleucine; D012694:Serine; D001377:Azaserine; D007930:Leucine
CYTOTOXIC DRUGS/metabolism; LEUCINE/related compounds; NEOPLASMS/metabolism; SERINE/related compounds